Loading…
Loading…
EQUITY / NYSE · XASE
Oragenics Inc.
Following is saved. Automatic company research is not available for this coverage; explore the evidence with Research.
No accepted understanding yet. Follow this company to establish research where evidence supports it.
Open research workspace →04/01/2026 – 06/30/2026 · USD · Units
Reported figures establish facts for this period; they do not by themselves establish a profitability trend.
Open report ↗0.5078 USD · 4.4641%
Observed: Oct 5, 2026, 11:41 PM · TickerLayer indicative price; may be delayed
Powered by TickerLayer
10/05/2026 · 0.4861 USD · Volume 42,474
20 actual observations · Latest bar: 2026-10-05 · Market data is indicative; provider terms apply.
8 available financial reports
Research reports →SEC FINANCIAL REPORTS
04/01/2026 – 06/30/2026 · Units
| Metric | 2026 / Quarter 2 | 2025 / Quarter 2 | Change |
|---|---|---|---|
| Operating profit | -2,592,528 USD | -1,714,202 USD | — |
| Net income | -2,528,707 USD | -2,272,035 USD | — |
| Cash and cash equivalents | 3,864,184 USD | — | — |
| Total liabilities | 1,821,867 USD | — | — |
| Total equity | 3,670,634 USD | -2,127,715 USD | — |
Changes are calculated only for matching period length, consolidation, currency, and scale. Percentages are not shown for zero or negative baselines.
Each column uses its report's scale. Check column headers before comparing different consolidation scopes and scales.
| Financial metric | 2026 / Quarter 204/01/2026 – 06/30/2026ConsolidatedUnits · USD | 2026 / Quarter 201/01/2026 – 06/30/2026ConsolidatedUnits · USD | 2026 / Quarter 201/01/2026 – 03/31/2026ConsolidatedUnits · USD | 2025 / Quarter 212/31/2025 – 12/31/2025ConsolidatedUnits · USD | 2025 / Year end01/01/2025 – 12/31/2025ConsolidatedUnits · USD | 2025 / Quarter 307/01/2025 – 09/30/2025ConsolidatedUnits · USD | 2025 / Quarter 301/01/2025 – 09/30/2025ConsolidatedUnits · USD | 2025 / Quarter 204/01/2025 – 06/30/2025ConsolidatedUnits · USD |
|---|---|---|---|---|---|---|---|---|
| Cash and cash equivalentsBalance sheet | 3,864,184 USD | — | — | 4,399,726 USD | 4,399,726 USD | 11,403,766 USD | — | — |
| Net incomeIncome statement | -2,528,707 USD | -4,729,950 USD | -2,201,243 USD | — | -9,842,487 USD | -3,066,589 USD | -7,555,617 USD | -2,272,035 USD |
| Operating profitIncome statement | -2,592,528 USD | -4,848,455 USD | — | — | -9,362,503 USD | -3,123,773 USD | -6,864,202 USD | -1,714,202 USD |
| Total assetsBalance sheet | 5,492,501 USD | — | — | 10,067,764 USD | 10,067,764 USD | 12,705,544 USD | — | — |
| Total equityBalance sheet | 3,670,634 USD | — | 6,181,758 USD | 8,281,405 USD | 8,281,405 USD | 9,831,436 USD | — | -2,127,715 USD |
| Total liabilitiesBalance sheet | 1,821,867 USD | — | — | 1,786,359 USD | 1,786,359 USD | 2,874,108 USD | — | — |
| Financing cash flowCash flow statement | — | -148,138 USD | — | — | 16,781,273 USD | — | 16,949,901 USD | — |
| Investing cash flowCash flow statement | — | 4,000,000 USD | — | — | — | — | — | — |
| Operating cash flowCash flow statement | — | -4,387,404 USD | — | — | -9,246,387 USD | — | -6,410,975 USD | — |
| Report source | Open report ↗ Published: 08/13/2026 | Open report ↗ Published: 08/13/2026 | Open report ↗ Published: 08/13/2026 | Open report ↗ Published: 08/13/2026 | Open report ↗ Published: 03/16/2026 | Open report ↗ Published: 11/07/2025 | Open report ↗ Published: 11/07/2025 | Open report ↗ Published: 08/13/2026 |
The latest available source version is shown for each period. Previous versions and correction relationships are not shown in this view.